Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change.

Bennett NR, Boyne MS, Cooper RS, Royal-Thomas TY, Bennett FI, Luke A, Wilks RJ, Forrester TE.

Clin Endocrinol (Oxf). 2009 Mar;70(3):408-14. doi: 10.1111/j.1365-2265.2008.03344.x. Epub 2008 Jul 7.

PMID:
18624998
2.

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

Diabetes Care. 2006 Nov;29(11):2498-503.

PMID:
17065691
3.

Isoprostanes, a marker of lipid peroxidation, may not be involved in the development of glucose intolerance.

Boyne MS, Sargeant LA, Bennett FI, Wilks RJ, Cooper RS, Forrester TE.

Diabetes Res Clin Pract. 2007 Apr;76(1):149-51. Epub 2006 Sep 7.

PMID:
16956690
4.

Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans.

Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY.

Diabetes Care. 2003 Mar;26(3):650-5.

PMID:
12610016
5.

Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

Hanley AJ, Connelly PW, Harris SB, Zinman B.

Diabetes Care. 2003 Dec;26(12):3219-25.

PMID:
14633805
6.

Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.

Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A.

Horm Metab Res. 2006 Mar;38(3):178-82.

PMID:
16673209
7.

Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study.

Klein DJ, Aronson Friedman L, Harlan WR, Barton BA, Schreiber GB, Cohen RM, Harlan LC, Morrison JA.

Diabetes Care. 2004 Feb;27(2):378-83.

PMID:
14747217
8.

Low plasma adiponectin concentrations do not predict weight gain in humans.

Vozarova B, Stefan N, Lindsay RS, Krakoff J, Knowler WC, Funahashi T, Matsuzawa Y, Stumvoll M, Weyer C, Tataranni PA.

Diabetes. 2002 Oct;51(10):2964-7.

9.

Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

Viswanathan V, Clementina M, Nair BM, Satyavani K.

J Assoc Physicians India. 2007 Dec;55:833-7.

PMID:
18405128
10.

The preservation of insulin sensitivity in obese women without diabetes.

Ngarmukos C, Chanprasertyothin S, Puavilai G, Ongphiphadhanakul B.

J Med Assoc Thai. 2008 May;91(5):659-64.

PMID:
18672628
11.

Effect of growth in infancy on body composition, insulin resistance, and concentration of appetite hormones in adolescence.

Larnkjaer A, Schack-Nielsen L, Mølgaard C, Ingstrup HK, Holst JJ, Michaelsen KF.

Am J Clin Nutr. 2010 Jun;91(6):1675-83. doi: 10.3945/ajcn.2009.27956. Epub 2010 Apr 21.

PMID:
20410092
12.

Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.

Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torréns JI, Kravitz HM, Bromberger JT, Matthews KA.

Diabetes Care. 2004 Dec;27(12):2856-62.

PMID:
15562197
13.

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

Kanaya AM, Wassel Fyr C, Vittinghoff E, Harris TB, Park SW, Goodpaster BH, Tylavsky F, Cummings SR.

Arch Intern Med. 2006 Feb 13;166(3):350-6.

PMID:
16476877
14.

Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.

Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kario K.

Hypertens Res. 2007 Jan;30(1):23-30.

PMID:
17460368
15.

Plasma adiponectin levels and incident glucose intolerance in Japanese-Brazilians: a seven-year follow-up study.

Vendramini MF, Ferreira SR, Gimeno SG, Kasamatsu TS, Miranda WL, Moisés RS; Japanese-Brazilians Diabetes Study Group.

Diabetes Res Clin Pract. 2006 Sep;73(3):304-9. Epub 2006 Mar 20.

PMID:
16546285
16.

Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity.

Pinar M, Gulsun M, Tasci I, Erdil A, Bolu E, Acikel C, Doruk A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):135-9. Epub 2007 Aug 8.

PMID:
17825464
17.

Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery.

Libè R, Morpurgo PS, Cappiello V, Maffini A, Bondioni S, Locatelli M, Zavanone M, Beck-Peccoz P, Spada A.

Clin Endocrinol (Oxf). 2005 Jan;62(1):30-6.

PMID:
15638867
18.

Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.

Lü Q, Tong N, Liu Y, Li N, Tang X, Zhao J, Cao H, Li D, Gou L, Zhang Y, Wan J, Jiang L.

Diabetes Res Clin Pract. 2009 Jun;84(3):319-24. doi: 10.1016/j.diabres.2009.03.002.

PMID:
19442860
19.
20.

Prospective investigation of metabolic characteristics in relation to weight gain in older adults: the Hoorn Study.

Wedick NM, Snijder MB, Dekker JM, Heine RJ, Stehouwer CD, Nijpels G, van Dam RM.

Obesity (Silver Spring). 2009 Aug;17(8):1609-14. doi: 10.1038/oby.2008.666. Epub 2009 Feb 5.

Supplemental Content

Support Center